» Articles » PMID: 32609538

Intrathecal Injection of Brilliant Blue G, a P2X7 Antagonist, Attenuates the Exercise Pressor Reflex in Rats

Overview
Specialty Physiology
Date 2020 Jul 2
PMID 32609538
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purinergic 2X (P2X) receptors on the endings of group III and IV afferents play a role in evoking the exercise pressor reflex. Particular attention has been paid to P2X3 receptors because their blockade in the periphery attenuated this reflex. In contrast, nothing is known about the role played by P2X receptors in the spinal cord in evoking the exercise pressor reflex in rats. P2X7 receptors, in particular, may be especially important in this regard because they are found in abundance on spinal glial cells and may communicate with neurons to effect reflexes controlling cardiovascular function. Consequently, we investigated the role played by spinal P2X7 receptors in evoking the exercise pressor reflex in decerebrated rats. We found that intrathecal injection of the P2X7 antagonist brilliant blue G (BBG) attenuated the exercise pressor reflex (blood pressure index: 294 ± 112 mmHg·s before vs. 7 ± 32 mmHg·s after; < 0.05). Likewise, intrathecal injection of minocycline, which inhibits microglial cell output, attenuated the reflex. In contrast, intrathecal injection of BBG did not attenuate the pressor response evoked by intracarotid injection of sodium cyanide, a maneuver that stimulated carotid chemoreceptors. Moreover, injections of BBG either into the arterial supply of the contracting hindlimb muscles or into the jugular vein did not attenuate the exercise pressor reflex. Our findings support the hypothesis that P2X7 receptors on microglial cells within the spinal cord play a role in evoking the exercise pressor reflex.

Citing Articles

Sex differences in the purinergic 2 receptor-mediated blood pressure response to treadmill exercise in rats with simulated peripheral artery disease.

Butenas A, Flax J, Carroll R, Chuwonganant C, Baranczuk A, Copp S Am J Physiol Regul Integr Comp Physiol. 2024; 326(6):R449-R460.

PMID: 38497127 PMC: 11381033. DOI: 10.1152/ajpregu.00010.2024.


Epidural and Intrathecal Drug Delivery in Rats and Mice for Experimental Research: Fundamental Concepts, Techniques, Precaution, and Application.

Rahman M, Lee J, Kim Y, Park C Biomedicines. 2023; 11(5).

PMID: 37239084 PMC: 10216595. DOI: 10.3390/biomedicines11051413.


A narrative review of methane in treating neurological diseases.

Ye Z, Fan D, Zhang T Med Gas Res. 2023; 13(4):161-164.

PMID: 37077112 PMC: 10226695. DOI: 10.4103/2045-9912.372663.


Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway.

DAmico R, Fusco R, Siracusa R, Impellizzeri D, Peritore A, Gugliandolo E Int J Mol Sci. 2021; 22(12).

PMID: 34208781 PMC: 8234677. DOI: 10.3390/ijms22126471.

References
1.
McCord J, Tsuchimochi H, Kaufman M . P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex. J Appl Physiol (1985). 2010; 109(5):1416-23. PMC: 2980379. DOI: 10.1152/japplphysiol.00774.2010. View

2.
Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Collo G, Buell G . ATP-mediated cytotoxicity in microglial cells. Neuropharmacology. 1997; 36(9):1295-301. DOI: 10.1016/s0028-3908(97)00137-8. View

3.
Hayes S, McCord J, Koba S, Kaufman M . Gadolinium inhibits group III but not group IV muscle afferent responses to dynamic exercise. J Physiol. 2008; 587(Pt 4):873-82. PMC: 2669976. DOI: 10.1113/jphysiol.2008.164640. View

4.
Ralevic V, Burnstock G . Receptors for purines and pyrimidines. Pharmacol Rev. 1998; 50(3):413-92. View

5.
Bin Dayel A, Evans R, Schmid R . Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket. Mol Pharmacol. 2019; 96(3):355-363. PMC: 6701605. DOI: 10.1124/mol.119.116715. View